The Board of Directors of Nanjing Haichen Pharmaceutical Co., Ltd. has assessed the independence of its independent directors. The assessment confirms that the independent directors meet the qualifications and independence requirements stipulated by regulations. This routine filing ensures compliance with corporate governance standards.
Summary generated by AI · Always verify with source document
Stock Code: 300584 Stock Abbreviation: Haichen Pharmaceutical Announcement Number: 2026-009
Nanjing Haichen Pharmaceutical Co., Ltd. Board of Directors' Special Opinion on the Independence of Independent Directors
The Company and all members of the Board of Directors guarantee that the content of the information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.